Pembrolizumab works by blocking a mechanism that cancer cells use to evade detection by the immune system, according to Drugs.com. The U.S. Food and Drug Administration (FDA) first approved it in 2014 ...
New results from a clinical trial co-led by UCLA investigators demonstrate how treating desmoplastic melanoma, a rare and ...
New results from a clinical trial co-led by UCLA investigators demonstrate how treating desmoplastic melanoma, a rare and ...
GlobalData on MSN
Moderna’s cancer vaccine plus Keytruda boosts RFS in melanoma study
A combination of intismeran autogene and Keytruda significantly prolonged recurrence-free survival in melanoma.
In patients with high-risk melanoma, the personalized cancer vaccine intismeran autogene and Keytruda reduced the risk of ...
10don MSN
Promising vaccine for aggressive melanoma could unlock the body’s potential to fight cancer
A personalised mRNA vaccine developed by Moderna and Merck shows lasting benefits for patients with high-risk skin cancer.
Long-term follow-up data from a phase 2b trial of Moderna and MSD's mRNA-based vaccine against melanoma, intismeran autogene (mRNA-4157), show an impressive 49% reduction in the risk of disease ...
A diagnosis of uveal melanoma marks the beginning of a long-term relationship with your medical team. While the focus starts with the eye, long-term care also includes regular monitoring of the liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results